Araloside C
Modify Date: 2025-09-26 07:30:50
Araloside C structure
|
Common Name | Araloside C | ||
|---|---|---|---|---|
| CAS Number | 55446-15-6 | Molecular Weight | 1089.22 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C53H84O23 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Araloside CAraloside C exhibits protective effects against myocardial ischaemia/reperfusion injury[1]. |
| Name | Araloside C |
|---|
| Description | Araloside C exhibits protective effects against myocardial ischaemia/reperfusion injury[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Araloside C also up-regulates the expression levels of Hsp90 and improved cell viability in hypoxia/reoxygenation-treated H9c2 cardiomyocytes, whereas the addition of 17-AAG, a pharmacologic inhibitor of Hsp90, attenuates Araloside C-induced cardioprotective effect[1]. Araloside C (0.5-2.5 μM) concentration-dependently improves the functional recovery of the I/R hearts, including increase in the recovery of LVDP, dP/dtmax and heart rate throughout the reperfusion period, although the baseline mechanical parameters with Araloside C were not significantly different compared with those of the control condition[1]. Araloside C could improve post-ischaemic cell shortening and Ca2+ transients from 2 to 8 μM[1]. |
| References |
| Molecular Formula | C53H84O23 |
|---|---|
| Molecular Weight | 1089.22 |
| InChIKey | DBUJWVDNMXCCKD-MVIACUKKSA-N |
| SMILES | CC1(C)CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(OC7OCC(O)C(OC8OC(CO)C(O)C(O)C8O)C7O)C(O)C6O)C(C)(C)C5CCC43C)C2C1 |